Re: All-cause mortality in randomized trials of cancer screening - Response

被引：6
|
作者：
Black, WC
Haggstrom, DA
Welch, HG
机构：
[1] Dartmouth Hitchcock Med Ctr, Dept Radiol, Lebanon, NH 03756 USA
[2] Dartmouth Coll Sch Med, Ctr Evaluat Clin Sci, Dept Community & Family Med, Hanover, NH USA
[3] Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA
[4] Dartmouth Coll Sch Med, Dartmouth Hitchcock Med Ctr, Dept Community & Family Med, Ctr Evaluat Clin Sci,Dept Med, Hanover, NH USA
[5] Vet Affairs Hosp, VA Outcomes Grp, White River Jct, VT USA
来源：
JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2002年 / 94卷 / 11期
关键词：
D O I：
10.1093/jnci/94.11.865
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：865 / 866
页数：2
相关论文
共 50 条
  • [21] Faecal haemoglobin concentrations are associated with all-cause mortality and cause of death in colorectal cancer screening
    Kaalby, Lasse
    Deding, Ulrik
    Al-Najami, Issam
    Berg-Beckhoff, Gabriele
    Bjorsum-Meyer, Thomas
    Laurberg, Tinne
    Shaukat, Aasma
    Steele, Robert J. C.
    Koulaouzidis, Anastasios
    Rasmussen, Morten
    Kobaek-Larsen, Morten
    Baatrup, Gunnar
    BMC MEDICINE, 2023, 21 (01)
  • [22] Obesity: Focus on all-cause mortality and cancer
    Teucher, Birgit
    Rohrmann, Sabine
    Kaaks, Rudolf
    MATURITAS, 2010, 65 (02) : 112 - 116
  • [23] Beta carotene increases all-cause mortality and cardiovascular death: A pooled analysis of randomized trials
    Vivekananthan, DP
    Penn, MS
    Sapp, SS
    Topol, EJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 532A - 532A
  • [24] Intensive statin therapy and all-cause mortality: a meta-analysis of randomized controlled trials
    Afilalo, J.
    Majdan, A. A.
    Eisenberg, M. J.
    EUROPEAN HEART JOURNAL, 2006, 27 : 855 - 856
  • [25] Intentional Weight Loss and All-Cause Mortality: A Meta-Analysis of Randomized Clinical Trials
    Kritchevsky, Stephen B.
    Beavers, Kristen M.
    Miller, Michael E.
    Shea, M. Kyla
    Houston, Denise K.
    Kitzman, Dalane W.
    Nicklas, Barbara J.
    PLOS ONE, 2015, 10 (03):
  • [26] All-Cause Mortality in Randomized Controlled Trials of Type 2 Diabetes: An Updated Systematic Review
    Barkoudah, Ebrahim
    Claggett, Brian L.
    Pfeffer, Marc A.
    DIABETES, 2017, 66 : A113 - A113
  • [27] Cancer and All-Cause Mortality: Meta-Analysis of Randomised Clinical Trials of Metformin
    Stevens, Richard
    Mclellan, Julie
    Cairns, Ben
    Ali, Raghib
    Bankhead, Clare
    Bethel, Angelyn
    Crowe, Francesca
    Farmer, Andrew
    Harrison, Sian
    Hirst, Jennifer
    Perera, Rafael
    Pluddemann, Annette
    Rose, Peter
    Home, Philip
    Kahn, Steven
    Ramachandran, Ambady
    Schweizer, Anja
    Viberti, Giancarlo
    Camisasca, Riccardo
    Holman, Rury
    DIABETES, 2011, 60 : A260 - A260
  • [28] EFFECT OF RALOXIFENE ON ALL-CAUSE MORTALITY ACROSS CLINICAL TRIALS
    Grady, D.
    Cauley, J.
    Stock, J.
    Cox, D.
    Mitlak, B.
    Song, J.
    Cummings, S.
    OSTEOPOROSIS INTERNATIONAL, 2009, 20 : 13 - 13
  • [29] Modelling of Endpoint Postponement for All-Cause Mortality in Statin Trials
    Hansen, Morten Rix
    Pottegard, Anton
    Hrobjartsson, Asbjorn
    Damkier, Per
    Christensen, Rene D.
    Larsen, Kasper Soltoft
    Kristensen, Malene E. L.
    Christensen, Palle M.
    Hallas, Jesper
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 1 - 1
  • [30] EFFECT OF RALOXIFENE ON ALL-CAUSE MORTALITY ACROSS CLINICAL TRIALS
    Grady, Deborah
    Cauley, Jane A.
    Stock, John L.
    Cox, David A.
    Mitlak, Bruce H.
    Song, Jingli
    Cummings, Steven R.
    OSTEOPOROSIS INTERNATIONAL, 2009, 20 : S206 - S207
12345